Evidence map›Paper›PMID 30629068›Full record

ArticleOrganic & biomolecular chemistry2019

Design criteria for minimalist mimics of protein-protein interface segments.

Jaru Taechalertpaisarn, Rui-Liang Lyu, Maritess Arancillo, Chen-Ming Lin, Zhengyang Jiang, Lisa M Perez, Thomas R Ioerger, Kevin Burgess

Abstract read
In one paragraph

Article in Organic & biomolecular chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Piptides: New, Easily Accessible Chemotypes For Interactions With Biomolecules.Angewandte Chemie (International ed. in English) · 2021
    Article
  3. Article
  4. Unconventional Secondary Structure Mimics: Ladder-Rungs.Angewandte Chemie (International ed. in English) · 2020
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jaru TaechalertpaisarnDepartment of Chemistry and Laboratory For Molecular Simulation, Texas A & M University, Box 30012, College Station, TX 77842-3012, USA. burgess@tamu.edu.
Rui-Liang Lyu
Maritess Arancillo
Chen-Ming Lin
Zhengyang Jiang
Lisa M Perez
Thomas R Ioerger
Kevin Burgess

Funding

Evaluation Of Trk Probes In Models For Dry Eye DiseaseR01EY029695 · NEI · TEXAS A&M UNIVERSITY · PI BURGESS, KEVIN · 2019 to 2021
$1.7M
Small Molecules To Inhibit PCSK9-LDLRR41HL126346 · NHLBI · SMALL MOLECULE PPI MIMICS, LLC · PI BURGESS, KEVIN · 2015 to 2015
$225k
NEI NIH HHS R01 EY029695NHLBI NIH HHS R41 HL126346
6 · The paper itself

Abstract

Small molecules that can interrupt or inhibit protein-protein interactions (PPIs) are valuable as probes in chemical biology and medicinal chemistry, but they are also notoriously difficult to develop. Design of non-peptidic small molecules that mimic amino acid side-chain interactions in PPIs ("minimalist mimics") is seen as a way to fast track discovery of PPI inhibitors. However, there has been little comment on general design criteria for minimalist mimics, even though such guidelines could steer construction of libraries to screen against multiple PPI targets. We hypothesized insight into general design criteria for minimalist mimics could be gained by comparing preferred conformations of typical minimalist mimic designs against side-chain orientations on a huge number of PPI interfaces. That thought led to this work which features nine minimalist mimic designs: one from the literature, and eight new "hypothetical" ones conceived by us. Simulated preferred conformers of these were systematically aligned with >240 000 PPI interfaces from the Protein Data Bank. Conclusions from those analyses did indeed reveal various design considerations that are discussed here. Surprisingly, this study also showed one of the minimalist mimic designs aligned on PPI interface segments more than 15 times more frequently than any other in the series (according to uniform standards described herein); reasons for this are also discussed.

Indexed as

Drug DesignCyclin-Dependent Kinase 2Databases, ProteinDNA-Directed RNA PolymerasesEnzyme InhibitorsHumansMolecular Dynamics SimulationMolecular StructureProtein BindingSmall Molecule LibrariesStereoisomerismCDK2 protein, humanCyclin-Dependent Kinase 2DNA-Directed RNA PolymerasesEnzyme InhibitorsSmall Molecule Libraries

Identifiers

PMID30629068
PMCPMC6344279

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.